Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Breast Neoplasms, Male × Testosterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 4 Albumin-Bound Paclitaxel 4 Trastuzumab 3 Gemcitabine 3 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3 pazopanib 2 Taxes 2 Sorafenib 2 Radiation 2 Paclitaxel 2 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2 Lapatinib 2 Doxorubicin 2 Docetaxel 2 romidepsin 1 rV-Tricom 1 peginterferon alfa-2a 1 pegfilgrastim 1 oblimersen 1 methyl N-acetylsibirosaminide 1 ixabepilone 1 fludarabine phosphate 1 fludarabine 1 exemestane 1 cediranib 1 alvocidib 1 Zoledronic Acid 1 Whole-Body Irradiation 1 Vorinostat 1 Vinorelbine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05156606 2024-08-09

T&T

University Medical Center Groningen

Phase NA Terminated

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡